Current diagnostic approaches depend on cognitive testing, imaging, and invasive procedures such as cerebrospinal fluid analysis. These techniques are expensive and not always definitive. Finding ...

New findings presented at the 2025 Alzheimer’s Association International Conference (AAIC) in Toronto spotlighted the long-term potential of two FDA-approved Alzheimer’s treatments for people with ...

Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. Jerry Klauer, an Alzheimer's patient who received a ...

The Alzheimer’s Association offers resources to people diagnosed with Alzheimer’s, as well as loved ones and caretakers. The organization helps patients locate a doctor who fits their needs, provides ...